[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"urologic-injuries\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:urologic-injuries":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100604762","phase-4-the-clinical-research-of-traditional-chinese-medicine-compound-formulas-100604762",false,"NCT07153731","The Clinical Research of Traditional Chinese Medicine Compound Formulas","Observation on the Clinical Efficacy of Shenkangling in the Treatment of Renal Ischemia-reperfusion Injury (Kidney Deficiency and Blood Stasis Syndrome)","Inclusion Criteria:\n\n1. Fulfillment of western medical diagnostic criteria requiring renal ischemia-reperfusion surgical operation and renal artery clamping time ≤ 30 min\n2. Meets the criteria for Chinese medicine identification\n3. 18 ≤ age ≤ 65\n4. Voluntary participation with signed informed consent\n\nExclusion Criteria:\n\n1. Patients with stage 4 or 5 renal insufficiency or patients with acute renal failure\n2. Those with secondary factors such as systemic lupus erythematosus, drug-induced renal damage, etc. confirmed by examination\n3. Does not meet the diagnosis of renal ischemia-reperfusion injury\n4. Cases not within the scope of action of the drug\n5. Those who have been taking other related therapeutic drugs for a long period of time, e.g., taking Chinese medicines such as Jingui Shenqi Pills by mouth for a long period of time, or those who are unable to stop taking the medicines immediately.\n6. Advanced deformity, disability, loss of labor force\n7. Combined heart, brain, liver, hematopoietic system, endocrine system and other serious primary diseases and psychiatric patients\n8. Pregnant or lactating women\n9. Critically ill patients\n10. Other circumstances deemed inappropriate for inclusion in the study","ALL","18 Years","65 Years",{"count":20,"type":21},100,"ESTIMATED","INTERVENTIONAL",[24],"PHASE4","To observe the efficacy and safety of Shenkangling, a traditional Chinese medicine decoction, for renal ischemia-reperfusion injury, and to provide evidence-based medical evidence and ideas for clinical therapeutic use.",[27,28],"Urologic Injuries","Urology",[30,31,32],"Traditional Chinese Medicine","Renal Fibrosis","Renal Ischemia-reperfusion Injury","NOT_YET_RECRUITING","2025-09-03",{"date":36,"type":37},"2025-09-04","ACTUAL",{"date":39,"type":21},"2025-10-01",{"date":41,"type":21},"2027-07-01",{"name":43,"class":44},"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","OTHER"]